Co-founder and Scientific Director
Professor, Genome Sciences, University of Washington, USA
Professor Sibley was one of the group of four scientists who recognised the need for the work now carried out by WWARN, and who campaigned over five years for support, both professional and financial, to bring the concept to reality. Based in the USA, she has carried out research for over 30 years at the University of Washington, being appointed Professor of Genetics (now Genome Sciences) in 1976. Since 1992, Professor Sibley has focused on drug resistance in malaria, collaborating closely with researchers in Kenya. In 2006, Professor Sibley was appointed Affiliate Professor at the Seattle Biomedical Research Institute, Seattle, WA, and in 2008 became a Visiting Professor of Tropical Medicine in the Nuffield Department of Medicine, Oxford University. Her recent articles include 32 peer-reviewed publications on malaria, tuberculosis and drug resistance.
Education
1976 Post-doctoral fellowship in Biology, California Institute of Technology, CA, USA
1974 PhD (Biochemistry and Biophysics), University of California, San Francisco, CA, USA
1969 MS (Biology), University of Rochester, NY, USA
1965 BA (Biology), University of Rochester, NY, USA
Professional Associations
Board, ACT Consortium
Board, Liverpool-Malawi Wellcome Trust Unit, Blantyre, Malawi
Member, Expert Scientific Advisory Committee of the Medicines for Malaria Venture
Past Member, Council of the American Society of Tropical Medicine and Hygiene
Representative Publications
Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, Whitty CJ, and Rowland M. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med 2010; 7:e1000283.
Sibley CH, Guerin PJ, and Ringwald P. Monitoring antimalarial resistance: launching a cooperative effort. Trends Parasitol 2010; 26:221-4.
Hawkins, VN, Suzuki SM, Rungsihirunrat K, Hapuarachchi HC, Maestre A, Na-Bangchang K, and Sibley CH. Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase. Am J Trop Med Hyg 2009; 81:348-55.
Guerin PJ, Bates SJ, and Sibley CH. Global resistance surveillance: ensuring antimalarial efficacy in the future. Curr Opin Infect Dis 2009; 22:593-600.
Sibley CH, Barnes KI, Watkins WM, and Plowe CV. A network to monitor antimalarial drug resistance: a plan for moving forward. Trends Parasitol 2008; 24:43-8.
